RTI Surgical® Showcases Novel Spine Portfolio at ISASS19
April 03 2019 - 7:30AM
RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical
implant company, is the Platinum Partner at the International
Society for the Advancement of Spine Surgery’s 2019 Annual Meeting
(ISASS19) taking place April 3-5, 2019, in Anaheim, California.
“We are proud to be the Platinum Partner at ISASS19 and to share
more about our differentiated novel spine portfolio, including the
coflex® Interlaminar Stabilization® device and the SImmetry®
Sacroiliac Joint Fusion System,” said Camille Farhat, President and
CEO, RTI Surgical. “RTI has built an increasingly differentiated
spine portfolio, and with it we are increasing our focus on
providing training and support for surgeons, expanding our body of
clinical evidence supporting the efficacy of our implants and
improving patient access.”
RTI will showcase its novel spine portfolio at Booth 326. The
coflex device is a differentiated, minimally-invasive,
motion-preserving stabilization implant that is FDA PMA-approved
for the treatment of moderate to severe lumbar spinal stenosis
(LSS), inserted directly after a surgical decompression. The
SImmetry System is a minimally-invasive surgical solution that uses
proprietary decortication technology, bone graft and threaded
fixation to facilitate bone fusion, providing an opportunity for
long-term pain relief.
On April 3, from noon to 1:30 p.m. PDT in Room 263A, RTI will
host a lunch workshop, “Growing Your Spine Practice with Novel
Spine Therapies in the Digital Age.” The workshop will feature
speakers Dr. Andrew Fox, a neurosurgeon based in Los Angeles, and
Dr. Donald Kucharzyk, an orthopedic spine surgeon based in Crown
Point, Indiana.
“Now that the data and technology exist to better identify and
treat SI joint pain in patients, it’s critical we continue to
educate surgeons how to recognize the condition and the source of
the problem,” said Dr. Kucharzyk. “The SI joint is the ‘great
mimicker,’ often being confused with a herniated disc and other
lower back problems. I’m looking forward to the lunch workshop with
RTI and sharing my experiences and resources with surgeons to help
create better referral paths to treat more potential patients.”
About RTI Surgical Holdings, Inc. RTI
Surgical is a leading global surgical implant company providing
surgeons with safe biologic, metal and synthetic implants.
Committed to delivering a higher standard, RTI’s implants are used
in sports medicine, general surgery, spine, orthopedic and trauma
procedures and are distributed in nearly 50 countries. RTI has four
manufacturing facilities throughout the U.S. and Europe. RTI is
accredited in the U.S. by the American Association of Tissue Banks
and is a member of AdvaMed. For more information, please
visit www.rtix.com. Connect with us
on LinkedIn and Twitter.
Steve Cohen Media Contact scohen@rtix.com +1
847 648 0861
Molly Poarch Investor Contact mpoarch@rtix.com
+1 224 287 2661
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Sep 2023 to Sep 2024